Form 4 for MRNA Moderna
Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-14 · accession 0001127602-24-005364 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-16 | 2024-02-16 | MRNA | Hoge Stephen | Pres | S - Sale | $88.88 | -10.5K | 1.53M | -0.7% | -$937.0K | |
| 2024-02-16 | 2024-02-14 | MRNA | Hoge Stephen | Pres | A - Grant | $0.00 | +22.7K | 1.54M | +1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-16 | S | D | 10,542 | $88.88 | 1,528,433 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-14 | A | A | 22,694 | $0.00 | 1,538,975 | D | — | — |